ALFA FinderBSE filing, NSE: CMMHOSP. Summary written from the filing by ALFA Finder's alert engine.
Chennai Meenakshi Multispeciality Hospital Ltd: key numbers
- Share price
- ₹35.80
- Market cap
- ₹26.74 Cr
- Revenue (annual)
- ₹37.04 Cr
- Net profit (annual)
- ₹-1.12 Cr
- P/E (TTM)
- -31.3×Sector 55.1×
- Promoter holding
- 57.10%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chennai Meenakshi Multispeciality Hospital Ltd
All →Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Chennai Meenakshi Multispeciality Hospital Q2 FY27 Results: Net Loss of ₹0.3 Cr
Chennai Meenakshi Multispeciality Hospital Ltd reported revenue from operations of ₹8.6 Cr (-9.5% YoY) and a net loss of ₹0.3 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.3 Cr
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital's quarterly shareholding pattern shows promoters holding 57.10%. The routine filing reports no corporate action or event value.
Chennai Meenakshi Multispeciality Hospital Board Meeting Date
Chennai Meenakshi Multispeciality Hospital will hold a board meeting on 2 November 2026 to consider quarterly and half-year unaudited results. Trading window remains closed from 1 October until 48 hours after results.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Quarterly shareholding pattern for the period ended September 30, 2026, filed in compliance with SEBI Regulation 31(1)(b).
Chennai Meenakshi Multispeciality Hospital Board Meeting Outcome
Chennai Meenakshi Multispeciality Hospital Limited has reconstituted its Audit Committee and Stakeholders Relationship Committee following the recent cessation of certain directors from the Board.
Other legal & regulatory announcements
All →Thirumalai Chemicals Legal & Regulatory
Thirumalai Chemicals received a GST show cause notice for ₹10.62 lakh over FY2023-24 input tax credit. The company considers the demand erroneous and will respond.
- Value
- ₹0.11 Cr
YES Bank Legal & Regulatory
Yes Bank has filed a review petition in the Supreme Court seeking reconsideration of its AT1 bond write-down judgment. The write-down concerns ₹8,415 crore of bonds.
- Value
- ₹8,415 Cr
Jindal Poly Films Legal & Regulatory
Jindal Poly Films signed a 12-day standstill agreement with an investor and subsidiary JPFL Films to explore an amicable settlement regarding ongoing legal proceedings.
- Execution
- 12 days
Astron Paper & Board Mill Legal & Regulatory
Astron Paper explains its failure to meet filing deadlines (financial results, annual report) due to its ongoing Corporate Insolvency Resolution Process (CIRP).
Ganesh Benzoplast Legal & Regulatory
Ganesh Benzoplast disclosed an ex-parte court order in UC Credit's arbitration application over an alleged guarantee. The order seeks Rs 8.27 Crore security and attaches some properties.
- Value
- ₹8.27 Cr
Natural Capsules Legal & Regulatory
Natural Capsules was fined ₹10,000 each by NSE and BSE for short board-meeting notice. The company has paid the fines and cited a late valuation report.
- Value
- ₹0.00 Cr